학술논문

Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia
Document Type
Article
Source
In: Science Translational Medicine. (Science Translational Medicine, 31 May 2023, 15(698))
Subject
Language
English
ISSN
19466242
19466234